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Objective. The objective of this study was to evaluate the immunolocalization of bone morphogenetic protein 2 (BMP-2) after
autogenous block grafting covered or not with an e-PTFE membrane.
Study Design. Forty-eight rats were divided into 2 groups, autogenous block graft (B) and autogenous block graft  e-PTFE
membrane (MB), and were evaluated by immunohistochemistry at baseline and 3, 7, 14, 21, and 45 days.
Results. The largest number of positive cells in the recipient bed was observed after 3 days in both groups. At the graft
border, the largest number of positive cells was seen after 7 days in group B and after 14 days in group MB. The highest
proportion of staining in the graft was observed after 3 days in group B and after 21 days in group MB.
Conclusions. High proportions of stain were related to intense revascularization and osteogenesis. Except for the interface,
BMP-2 staining occurred later in group MB than in group B in all structures analyzed. (Oral Surg Oral Med Oral Pathol Oral
Radiol 2012;113:533-541)Autogenous bone has been recognized as the gold stan-
dard for bone grafting, providing osteogenic cells, ex-
tracellular matrix, and molecular signals for the induc-
tion of bone differentiation.1,2 The use of this type of
graft combined with a membrane for guided bone re-
generation (GBR) has yielded positive and predictable
clinical results.3-5 The advent of new techniques, such
as immunohistochemistry and in situ hybridization, has
permitted the study of osteogenesis and bone repair at
cellular and molecular levels.6
Bone morphogenetic proteins (BMPs), which reg-
ulate cellular proliferation, differentiation, and extra-
cellular matrix production, were first described by
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doi:10.1016/j.oooo.2011.09.016Marshall Urist in 1965,7 and are the best known and most
researched of the musculoskeletal growth factors.8
Bone morphogenetic protein 2 (BMP-2) plays an
important role in the cascade of cellular events that
regulate bone formation and repair, inducing the differ-
entiation and proliferation of mesenchymal cells and
the synthesis of extracellular matrix.9-13 BMPs are able
to induce the differentiation of undifferentiated cells
around blood vessels into osteoblasts and chondrocytes
and thus regulate bone formation.12-14 Before that
phase of cytodifferentiation is complete, cells aggregate
and proliferate in sites of condensation. At that mo-
ment, the concentration gradients of BMP are increased
in these sites of condensation. This characteristic justi-
fies the term morphogenetic protein.15
Concerning exogenous BMP-2, Springer et al.16 dem-
onstrated in rat mandibles that bone apposition of the
experimental versus control sides was not statistically
significantly different when one of the growth factors was
applied alone (rhBMP-2; basic fibroblast growth factor
[bFGF]). The application of bFGF and the application of
rhBMP-2 alone resulted in predictable bone generation in
the irradiated mandible with the bone apposition being
equal to that of the nonirradiated side. The application of
both growth factors together or none at all after irradiation
results in significantly reduced bone apposition. When an
antagonist of BMP-2, noggin protein, was applied in
2-month-old minipigs, the quantity and quality of sponta-
neous bone regenerates was not altered. No disruption of
subsequent cranial development was seen.17
Using an experimental rat model for the evaluation
of the early stages of bone repair, Jardini et al.18 dem-
onstrated that autogenous bone grafts combined with an
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result in more intense formation of new bone than
autogenous grafts alone. These significant differences
in the repair process were observed as early as 21 days
after surgery. In a complementary study, De Marco et
al.19 observed that revascularization was correlated
with the results obtained in the study of Jardini et al.18
Revascularization was more intense and extensive in
the group receiving the autogenous bone graft alone
when compared with the group treated with the mem-
brane-covered graft across all experimental periods.
Thus, revascularization was directly related to new
bone formation around the graft, as well as to graft
replacement with new bone or even to graft resorption
when grafts without a membrane were used. In the
same rat model, Nascimento et al.20 evaluated the in-
fluence of osteopenia in autogenous bone graft healing
with or without an e-PTFE membrane in rats. Osteope-
nia did not influence bone graft repair.
Studies have demonstrated the temporal and spatial
localization of BMP-2 during fracture healing14,21-24
and during distraction osteogenesis.25-27 Data regarding
the role of BMP-2 in guided bone regeneration (GBR)
or autogenous bone block grafts are scarce. Therefore,
the objective of the present study was to investigate the
immunolocalization of BMP-2 in autogenous bone
grafts covered or not with an e-PTFE membrane.
MATERIAL AND METHODS
The study protocol was approved by the Ethics Com-
mittee on Animal Experimentation of the Institute of
Biomedical Sciences, University of São Paulo (No.
073/03).
Forty-eight male Wistar rats weighing 250 to 300 g
were selected and divided into 2 groups: autogenous
bone block graft covered with an e-PTFE membrane
(WL Gore and Associates, Flagstaff, AZ) (group MB)
(Figure 1) and autogenous block graft (group B) (Fig-
ure 2).
The experimental model has been described in detail
by Jardini et al.18 and De Marco et al.19 Briefly, parietal
bone served as the bone graft donor site, whereas the
region of the mandibular angle was the recipient area.
Animals were humanely killed at baseline and 3, 7,
14, 21, and 45 days after surgery. Four animals per
group were used for each experimental period. The
animals were anesthetized and the hemimandible, in-
cluding the operated area, was fixed in 10% buffered
formalin for a maximum period of 48 hours. Each
specimen was recorded and then decalcified in 10%
EDTA, pH 7.8, in a microwave oven.
The sections were submitted to immunohistochem-
istry. Specimens in which the primary antibody was
replaced with bovine serum albumin and fetal bovineserum in Tris buffer were used as negative controls.
Human fetal (12 weeks) bone (rib and femur) was used
as positive control. The sections (3 m) were dewaxed,
rehydrated, and submitted to antigen retrieval in 0.5%
pepsin, pH 1.8, for 30 minutes at 37°C. The specimens
were then treated with 6% hydrogen peroxide/methanol
solution (1:1) for 30 minutes to block endogenous
peroxidase activity. Immunohistochemistry was per-
formed using the Dako Autostainer (Dako Corp.,
Carpinteria, CA). Briefly, the sections were incubated
with the primary anti-BMP-2 antibody (Santa Cruz
Biotechnology, Santa Cruz, CA) and diluted 1:10 for 30
minutes. Next, the sections were incubated with the
streptavidin-biotin complex (LSAB Peroxidase K0690
kit, Dako), followed by incubation with the Dako Liq-
uid DAB-Plus substrate-chromogen system (code
K3468) for 3 minutes. The sections were then counter-
stained with Mayer’s hematoxylin. Negative controls
were treated as described previously with a solution of
1% bovine serum albumin in Tris-HCl, pH 7.4 replac-
Fig. 1. Group MB—operated situs.
Fig. 2. Group B—operated situs.ing the primary antibody.
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formed. For descriptive analysis, all slides were exam-
ined under an Axioscope 2 Plus light microscope (Carl
Zeiss, Jena, Germany) at magnifications ranging from
250 to 630. Slides showing intracytoplasmic stain-
ing without a background reaction were selected for
cell counting. In each slide, images of consecutive areas
of the following structures were captured at 400
magnification: graft border, graft, connective tissue
above the graft, graft-host interface, and recipient bed.
The images were captured using an Axioscope 2 Plus
microscope (Carl Zeiss) coupled to a digital camera
(SV Micro—Sound and Vision, Boston, MA). This
system was connected to a computer and the Axio
Vision 3.0 program (Carl Zeiss) was used for analysis.
Quantitative analysis was performed by a calibrated
examiner who obtained an intraclass coefficient of cor-
relation of 0.993 (0.989 to 0.996) at P less than .001.
RESULTS
No clinical complications were observed after surgery
and none of the animals were lost during the experi-
ment.
A problem with some specimens and the immuno-
histochemistry technique was noted in this study. Many
sections were lost from the glass microscope slide.
Willbold and Witte32 describe an optimized and stan-
dardized embedding and cutting technique using Tech-
novit 9100 (Heraeus Kulzer, Germany). With this tech-
nique, it is possible to perform enzyme histochemistry,
immunohistochemistry, a great variety of classical his-
tologic stains, and even in situ hybridization, because
this new polymerization system, also based on methyl
methacrylate, polymerizes in the absence of oxygen
and at low temperatures, so the DNA or most of the
Fig. 3. Group B specimen 45 days. Photomicrograph show-
ing graft (G), receptor bed (RB), and connective tissue (CT)
(original magnification 40).proteins are not denatured.Descriptive analysis
At baseline, both groups (B and MB) presented discon-
tinuity and blood clotting in all structures analyzed. No
baseline intracytoplasmic BMP-2 staining was ob-
served in either group. At the end of the experiment, 45
days, all the structures were integrated in both groups B
(Figure 3) and MB (Figure 4).
Immunolocalization of BMP-2 in autogenous
bone block grafts
At 3 days, formation of new bone started in the inner
cortical zone of the recipient bed, the region most
distant from the graft. BMP-2 staining was seen in
osteocytes and osteoblasts of the recipient bed. No
staining was observed in the other structures. At 7 days,
BMP-2 immunostaining was seen in osteocytes and
osteoblasts of the recipient bed and in osteoprogenitor
Fig. 4. Group MB specimen 45 days. Photomicrograph
showing membrane (M), graft (G), receptor bed (RB), and
connective tissue (CT) (original magnification 40).
Fig. 5. Group B specimen 7 days. Photomicrograph showing
connective tissue (CT) above the graft (G). Osteoprogenitor
cells staining for BMP-2 (arrows) (original magnification
630).cells located at the graft-host interface, in connective
interface (original magnification 630). V, blood vessel.
cation 400).
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a region characterized by the onset of bone remodeling
(Figure 6). Fourteen days after surgery, BMP-2–posi-
tive cells were detected in the region of the graft border
(Figure 7) and in woven bone edges between the recip-
ient bed and graft. At 21 days, when bone graft inte-
gration with the recipient bed became evident, BMP-
2–positive cells were observed in immature trabecular
bone (interface) (Figure 8). Immunostaining was seen
in regions close to the perforation both in the recipient
and at the interface (Figure 9). Forty-five days after
surgery, the graft was integrated with the recipient bed.
Intracytoplasmic staining was observed in perivascular
cells located at the graft border (Figure 10). BMP-2
staining was also seen in the recipient bed, graft, and
Fig. 6. Group B specimen 7 days. Photomicrograph showing
osteoprogenitor cell staining for BMP-2 (arrow) on the graft
board (GB) beside an osteoclast (OC) (original magnification
630).
Fig. 7. Group B specimen 14 days. Photomicrograph show-
ing osteoprogenitor cells staining for BMP-2 on the graft
board (arrows) (original magnification 630).connective tissue above the graft.Fig. 8. Group B specimen 21 days. Photomicrograph show-
ing perivascular cells staining for BMP-2 (arrows) on theFig. 9. Group B specimen 21 days. Photomicrograph show-
ing osteocytes (green arrow), osteoblast (black arrow), and
osteoprogenitor cell (red arrow) staining for BMP-2 on the
receptor bed (RB) and on the interface (I) (original magnifi-Fig. 10. Group B specimen 45 days. Photomicrograph show-
ing the graft board with perivascular osteoprogenitor cells
staining for BMP-2 (arrows) (original magnification 400).
G, graft; V, blood vessels.
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bone block grafts covered with an e-PTFE
membrane
At 3 days, intracytoplasmic BMP-2 staining was seen
in the inner cortical zone of the recipient bed. Deposi-
tion of osteoid in resorption canals was observed in this
region of bone remodeling (Figure 11). BMP-2 staining
was seen in osteocytes and osteoblasts in this region
(Figure 12). Seven days after surgery, staining was seen
in osteocytes of the recipient bed and in osteoprogenitor
cells of young connective tissue found at the graft-host
interface. BMP-2–positive cells were observed at the
graft border (Figure 13) and in connective tissue above
the graft; regions located beneath the membrane. Os-
teocytes recently trapped inside the graft were also
Fig. 11. Group MB specimen 3 days. Photomicrograph
showing woven bone (*) and reversion lines (black arrows)
on the receptor bed (RB). Osteoblasts staining for BMP-2
(red arrows) (original magnification 200).
Fig. 12. Group MB specimen 3 days. Photomicrograph
showing osteoblasts (arrows) staining for BMP-2 depositing
woven bone (*) (original magnification 630).positive. At 14 days, intracytoplasmic staining wasobserved in areas of marked osteoblastic activity, such
as the interface and graft border.
Twenty-one days after surgery, integration of the
graft with the recipient bed and a large area of new
bone formation at the graft border were observed. This
period was characterized by extensive replacement of
destructured bone matrix with new matrix, indicating
bone remodeling in the graft. Intracytoplasmic staining
was observed inside the graft and at the graft borders;
regions characterized by the presence of osteoid and
reversal lines (Figure 14). Staining of osteoprogenitor
cells was seen in connective tissue above the graft, even
close to the membrane (Figure 15). BMP-2–positive
cells were observed in the recipient bed and at the
graft-host interface (Figure 16). Forty-five days after
Fig. 13. Group MB specimen 7 days. Photomicrograph
showing the graft board with osteoblasts staining for BMP-2
(arrows) and bone remodeling area (*) (original magnifica-
tion 400).
Fig. 14. Group MB specimen 21 days. Photomicrograph
showing substitution area on the graft (G). Osteocytes re-
cently imprisoned in the new matrix (black arrows) and
reversion line (red arrow) (original magnification 400).surgery, when the structures were completely inte-
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seen in the recipient bed, graft, and integration area
(interface), as well as at the graft border and in con-
nective tissue above the graft.
Quantitative analysis
The number of BMP-2–positive cells in the different
structures (graft border, recipient bed, graft, interface,
and connective tissue above the graft) was compared
between the B and MB groups.
At the graft border, the largest number of positive
cells was observed after 7 days in group B and after 14
days in group MB (Figure 17, A and B). In the graft, the
largest number of positive cells was observed after 3
days in group B and after 21 days in group MB,
although the mean number was similar across all ex-
Fig. 15. Group MB specimen 21 days. Photomicrograph
showing connective tissue (CT) above the graft. Osteopro-
genitor cells staining for BMP-2 (arrows) (original magnifi-
cation 400). V, blood vessels; M, membrane space.
Fig. 16. Group MB specimen 21 days. Photomicrograph
showing osteoprogenitor cells staining for BMP-2 (arrows)
on the interface (I) (original magnification 630).perimental periods (Figure 17, A and B). In connectivetissue above the graft, the largest number of positive
cells was seen after 7 days in group B and after 21 days
in group MB (Figure 17, A and B). The largest number
of positive cells at the graft-host interface was observed
after 21 days in group B and after 7 days in MB (Figure
17, A and B). In the recipient bed, the largest number of
positive cells was noted after 3 days in both groups (B
and MB) (Figure 17, A and B). The number of positive
cells was always lower at 45 days in all structures.
For all structures analyzed, no significant difference
in the number of BMP-2–positive cells was observed
between groups (B  MB) at any time point. In addi-
tion, no difference in BMP-2 immunolocalization was
observed over time in group B or group MB.
DISCUSSION
The present study defines and characterizes the pres-
ence, localization, and chronology of BMP-2 expres-
sion during wound healing after GBR using an onlay
autogenous graft covered or not with an e-PTFE mem-
brane. Immunolocalization of BMP-2 was evaluated in
the B and MB groups at different times after surgery
and in different structures. Overall analysis according
to structure showed a higher proportion of staining at
the graft border, at the graft-host interface, in connec-
tive tissue above the graft, and in the recipient bed,
irrespective of the group studied. Lower proportions
were observed in the graft. Analyzing the same struc-
ture, differences in staining were observed between
time points and between groups.
In the recipient bed, the largest number of positive
cells was observed after 3 days in groups B and MB.
No difference in BMP-2 staining in the recipient bed
was observed between groups during this early stage of
repair. During this phase, the periosteum reacts to stim-
uli received during surgery and undifferentiated mes-
enchymal cells or preosteoblasts proliferate. Vascular
buds are present in the more superficial region of the
recipient bed, which start to orient themselves in the
direction of the graft.19 Studies on fracture healing
reported cytoplasmic staining in proliferating osteo-
genic cells during the early stages after fracture cre-
ation.14,21,22,24 Studies investigating distraction osteo-
genesis25,26 observed expression of BMP-2, -4, and -7
immediately after surgery, even before the onset of the
distraction process. These data point to the expression
of BMP-2 during the early stage of bone healing.
The largest number of positive cells was detected at
the graft border on day 7 in group B and on day 14 in
group MB, with the observation of positive staining in
osteoblasts and osteoprogenitor cells in areas of bone
remodeling and of a large quantity of newly formed
bone. A slight decrease in the proportion of BMP-2
staining was observed after 14 days in both groups, but
OOOO ORIGINAL ARTICLE
Volume 113, Number 4 De Marco et al. 539positive cells were detected in this area of intense
osteogenic activity even after 21 and 45 days.
In connective tissue above the graft, the highest
proportion of BMP-2 staining was observed in osteo-
progenitor cells after 7 days in group B and after 21
days in group MB. However, a slight decrease in the
proportions of staining was observed between 7 and 45
days, with BMP-2–positive cells still being detected at
the end of the experiment. In agreement with these
findings, several investigators reported the expression
of BMP-2 in immature bone cells,24,26 multinucleated
cells (preosteoclasts),22,23 and osteoid28 during bone
repair 7 to 28 days after surgery. Onishi et al22 sug-
gested that BMP-2 and BMP-4 are involved in the
differentiation and maturation of osteoclasts; however,
in contrast with Onishi et al.,22 no staining of oste-
oclasts was observed in the present study.
Bone resorption and remodeling activity and the
onset of osteogenesis were observed at the graft border
and in the upper portion of the graft in group B between
7 and 14 days. The BMP-2 staining observed in group
B at the graft border and in connective tissue above the
graft is intimately related to the formation of a vascular
Fig. 17. A, Proportion of BMP-2 staining in group B at diff
group MB at different time points after surgery.plexus at the graft borders on day 7 and to the penetrationof vessels into the graft, permitting mesenchymal and
osteoprogenitor cells to arrive at the site and to act on the
remodeling process. The same event was observed in
group MB between 14 and 21 days. Thus, graft replace-
ment occurs earlier in group B than in group MB.18-20
At the graft-host interface, the largest number of
positive cells was observed between 7 and 21 days in
groups B and MB, respectively, with positive osteopro-
genitor cells being detected in areas of woven bone
edges between the recipient bed and graft. The graft,
bed, and interface practically formed a single structure
as early as day 21 after surgery.18 Newly formed blood
vessels penetrating almost throughout the graft were
observed during this period.19
In group B, the highest proportion of BMP-2 staining
at the graft-host interface was observed at 21 days (later
than in group MB), whereas in the other structures
analyzed, the highest proportion was observed during
earlier stages. Thus, BMP-2 immunostaining generally
occurs slightly later in group MB. This difference in the
predominant expression of BMP-2 and the time when it
occurs, as well as the difference between groups, might
be related to the more intense revascularization in
me points after surgery. B, Proportion of BMP-2 staining inerent tigroup B.19
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est number of positive cells being observed after 3 days
in group B and after 21 days in group MB. However, in
the 2 groups the proportion of staining was lower when
compared with that observed for the other structures. In
group MB, the membrane-covered graft did not come
into contact with surrounding connective tissue because
the diameter of the membrane exceeded the borders of
the graft, a fact that resulted in cell-mediated repair and
in a newly formed vascular network originating from
the recipient bed. Therefore, in group MB, revascular-
ization of the graft occurred from the recipient bed and
the weak staining for BMP-2 might be explained by this
slow revascularization and graft replacement.18,19
Marked proportions of staining were observed in the
region of the graft border, connective tissue above the
graft, interface, and recipient bed between 21 and 45
days, suggesting that BMP-2–positive cells are still
present at 45 days. These results agree with those
reported by Alam et al.,29 who evaluated bone regen-
eration after implantation of 3 different types of bone
graft. New bone formation was observed in the group
receiving the autogenous bone graft after 4 weeks, but
the number of BMP-2–positive cells was reduced. Sim-
ilar findings have been reported by Si et al.,14 Rauch et
al.,25 and Spector et al.23 Our results also demonstrated
a higher proportion of BMP-2–positive cells between 3
and 21 days and a lower number of positive cells at
subsequent time points.
The MB group presented higher proportions of stain-
ing during later periods of the early stage of healing in
all structures when compared with group B, except for
the recipient bed, in which a higher proportion of
staining was observed after 3 days in both groups, and
the graft-host interface, at which a higher proportion
was observed in group B after 21 days. Taken together,
these results indicate that areas showing a higher pro-
portion of staining are sites of more intense osteogenic
activity.
All of these observations are intimately related to the
process of graft revascularization described by De
Marco et al.19 In that study, revascularization was more
intense in group B and was accompanied by the pres-
ervation of structures and greater gain in bone volume
as demonstrated by Jardini et al.18 Revascularization
was also observed in group MB, but the process was
slower.
In the present study, BMP-2 antibody staining was
observed in osteoprogenitor cells, osteoblasts, and os-
teocytes located in areas of osteogenesis close to blood
vessels. McCullough et al.30 observed staining of
perivascular chondrocytes and suggested that diffusion
factors released by perivascular cells might be involved
in the differentiation and apoptosis of adjacent chon-drocytes. These authors, as well as Onishi et al.22 and
Spector et al.,23 found that BMP staining in osteoclasts
is variable, ranging from intense to moderate. BMPs
present in osteoclast cytoplasm may simply be the
result of phagocytosis of BMP-containing bone matrix.
However, it has been suggested that osteoclasts synthe-
size BMPs. The expression of BMPs by osteoclasts at
resorption sites during bone remodeling represents an
important mechanism of intercellular communication
that leads to the recruitment and differentiation of os-
teoblasts.31 The expression of BMP-2 in osteoclastlike
multinucleated cells also suggests that BMPs are in-
volved in the differentiation and maturation of oste-
oclasts.22
CONCLUSIONS
Intracytoplasmic staining of BMP-2 was consistently
observed in areas of revascularization and osteogenesis.
Intracytoplasmic BMP-2 staining was seen in osteopro-
genitor cells, osteoblasts, and osteocytes, irrespective
of the period or structure analyzed. The highest propor-
tions of staining were observed at the graft border and
graft-host interface, in connective tissue above the
graft, and in the recipient bed, whereas the lowest
proportion was detected in the graft. Except for the
interface, BMP-2 staining occurred later in group MB
than in group B in all structures analyzed.
The investigators thank Prof. Dr. Claudio Mendes Pannuti
for his help with results analysis.
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